PMDA — authorised 24 March 2014
- Marketing authorisation holder: DAIICHI SANKYO COMPANY, LIMITED
- Status: approved
PMDA authorised Effient on 24 March 2014
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. PMDA authorised it on 24 March 2014.
DAIICHI SANKYO COMPANY, LIMITED holds the Japanese marketing authorisation.